Retatrutide differs from other approved weight-loss injections such as

Mounjaro and Wegovy because it targets three hormone receptors, rather than one or two. This triple hormone receptor action may lead to greater weight loss, although direct comparisons in head-to-head clinical trials are still limited. Research suggests it may offer additional metabolic benefits beyond appetite suppression alone.

What is retatrutide?

A new triple hormone weight loss injection in development

Retatrutide is a once-weekly weight loss injection that targets three hormones: GLP-1, GIP, and glucagon.

According to Eli Lilly clinical data, this “triple G” mechanism sets Retatrutide apart from Wegovy, which targets one hormone, and Mounjaro, which targets two. Retatrutide is the first triple-agonist therapy in development for obesity, combining the actions of three key metabolic hormones.

This “triple G” effect is what makes Retatrutide one of the most advanced treatments in development. In clinical trials, it led to greater weight loss than any currently available medication.

How does retatrutide work in the body?

• Buy retatrutide online uk for sale helps with weight loss by mimicking hormones that reduce hunger, slow digestion, and increase energy use.
• GLP-1 stimulates the release of insulin, slows your digestion, and helps suppress your appetite.
• GIP enhances insulin release and may work to prevent fat buildup.
• GCG may increase the amount of energy your body uses while helping to burn fat.

This triple mechanism helps reduce hunger, improve insulin sensitivity, and may increase the number of calories your body burns, all of which support sustained and meaningful weight loss.

Current research is still ongoing and we are still learning exactly how this triple action translates into long term benefits and risks.